Onkologie. 2018:12(5):248-253 | DOI: 10.36290/xon.2018.045

Management of physical symptoms in patient with glioblastoma multiforme from the nurse perspective

Dominika Kalánková1, Daniela Bartoníčková2, Katarína Žiaková3
1 Ústav ošetrovateľstva, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave
2 Neurologická klinika 2. LF a FN Motol, Fakultní nemocnice v Motole, Praha
3 Ústav ošetrovateľstva, Jesseniova lekárska fakulta v Martine, Univerzita Komenského v Bratislave

Glioblastoma multiforme is the most common and aggressive primary brain tumor, whereby the prognosis in diagnosed patientsis infaust. Nursing care is complex, with emphasis on physical symptoms which are the most annoying for patients. Amongst themost significant symptoms belong to a headache, fatigue, seizures and cognitive impairment. Except for these symptoms, patientsoften experience side effects of very aggressive treatment which have a negative impact on the patient lives through the wholedisease trajectory. Regarding this, the emphasis is placed on the quality of provided nursing care. The overview article aimed todescribe the most significant annoying symptoms in patients with glioblastoma multiforme and to give its nursing management.

Keywords: cognitive impairment, fatigue, glioblastoma multiforme, headache, physical symptoms, seizures

Published: October 15, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kalánková D, Bartoníčková D, Žiaková K. Management of physical symptoms in patient with glioblastoma multiforme from the nurse perspective. Onkologie. 2018;12(5):248-253. doi: 10.36290/xon.2018.045.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Davis ME, Mulligan Stoiber AM. Glioblastoma multiforme: enhancing survival and quality of life. Clin J Oncol Nurs 2011; 15(3): 291-297. Go to original source... Go to PubMed...
    2. Davis ME. Glioblastoma: overview of disease and treatment. Clin J Oncol Nurs 2016; 20(5): 2-8. Go to original source...
    3. Champaneria NN, Shan SR, Goswami SS. Glioblastoma multiforme in 56 years old patient - A case report. IAIM 2017; 4(1): 127-130. Available from: http://iaimjournal.com/wp-content/uploads/2017/01/iaim_2017_0401_19.pdf
    4. Boele FW, Given CW, Given BA, et al. Family caregivers' level of mastery predicts survival of patients with glioblastoma: a preliminary report. Cancer 2017; 123(5): 832-840. Go to original source...
    5. Lin E, Rosenthal MA, Le BH, et al. Neuro-oncology and palliative care: a challenging interface. J Neuro Oncol 2012; 14(Suppl. 4): iv3-iv7. Go to original source...
    6. Catt S, Chalmers A, Fallowfield L. Psychosocial and supportive-care needs in high-grade glioma. The Lancet Oncol 2008; 9(9): 884-891. Go to original source... Go to PubMed...
    7. Boele FW, Rooney A, Grant R, et al. Psychiatric symptoms in glioma patients: from diagnosis to management. Neuropsychiatr Dis Treat 2015;11: 1413-1420. Go to original source...
    8. De Mahalhaes KCSF, Vaz II MPJ, Gontijo MAP, et al. Profile of patients with brain tumors and the role of nursing care. Rev bras enferm 2016; 69(1): 138-143. Go to original source... Go to PubMed...
    9. Reddy K, Gaspar LE, Kavanach BD, et al. Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide. J Neuro Oncol 2014; 114(1): 111-116. Go to original source...
    10. Vargo M, Henriksson R, Salander P. Rehabilitation of patients with glioma. In: BEERGER, Mitchel S. a Michael Weller. Gliomas (online). Amsterdam: Elsevier 2016: s. 287-304. Handbook of Clinical Neurology, vol. 134.ISBN 978-0-12-802997-8.Dostupné z: http://www.brainlife.org/fulltext/2016/_Vargo_M160000.pdf Go to original source...
    11. Alifieris C, Trafalis DT. Glioblastoma multiforme: Pathogenesis and treatment. Pharmacol Ther 2015; 152(Aug): 63-82. Go to original source...
    12. Vargo M. Brain tumor rehabilitation. A J Phys Med Rehabil 2011; 90(5, Suppl. 1): 50-62. Go to original source...
    13. Lovely MP. Symptom management of brain tumor patients. Semin Oncol Nurs 2004; 20(4): 273-283. Available from: https://www.ncbi.nlm.nih.gov/pubmed/15612603 Go to original source... Go to PubMed...
    14. Cahill J, Lobiondo-Wood G, Bergstrom N, et al. Brain tumor symptoms as antecedents to uncertainty: an integrative review. J Nurs Scholarsh 2012; 44(2): 145-155. doi:10.1111/j.1547-5069.2012.01445.x Go to original source... Go to PubMed...
    15. Bennett RS, Cruickshank G, Lindenmeyer A, et al. Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study. BMJ Open 2016; 6(11): 1-7. doi:10.1136/bmjopen-2016-011616 Go to original source...
    16. Fritz L, Dirven L, Reijneveld JC, et al. Advance care planning in glioblastoma patients. Cancers 2016; 8(11): 1-9. Go to original source...
    17. Omuro A, Deangelis LM. Glioblastoma and other malignant gliomas: a clinical review. JAMA 2013; 310(17): 1842-1850. Go to original source... Go to PubMed...
    18. Twycross R, Wilcock A. Symptom Management in Advanced Cancer. 3. vyd. Oxford: Radcliffe, Medical Press. 2002: 417 s.
    19. Kurucová R, Žiaková K, Gurková E, et al. Occurrence of annoying symptoms of patients with cancer. Cent Eur J Nurs Midwifery 2015; 6(1): 185-190. Go to original source...
    20. Lovely MP. Care of the adult patient with a brain tumor: AANN clinical practice guideline series 2014 (online). Chicago (IL): American Association of Neuroscience Nurses (cit. 2017-03-10). Dostupné z: http://www.abta.org/resources/health-care-provider/final-adult-clinical-practice.pdf
    21. Molassiotis A, Wilson B, Brunton L, et al. Symptom experience in patients with primary brain tumours: a longitudinal exploratory study. Eur J Oncol Nurs 2010; 14(5): 410-416. Go to original source... Go to PubMed...
    22. Liu, R, Page M, Solheim K, et al. Quality of life in adults with brain tumors: current knowledge and future directions. J Neuro Oncol 2009; 11(3): 330-339. Go to original source...
    23. Valko OP, Siddique A, Linsenmeier C, et al. Prevalence and predictors of fatigue in glioblastoma: a prospective study. Neuro Oncol 2015; 17(2): 274-281. Go to original source... Go to PubMed...
    24. Peters BK, West MJ, Hornsby WE, et al. Impact of health-related quality of life and fatigue on survival of recurrent high-grade glioma patients. J Neuro Oncol 2014; 120(3): 499-506. Go to original source... Go to PubMed...
    25. Berger MA, Mitchell SA, Jacobsen PB, et al. Screening, evaluation, and management of cancer-related fatigue: ready for implementation to practice? CA: Cancer J Clin 2015; 65(3): 190-211. Go to original source...
    26. Hofman M, Ryan JL, Figueroa-Moseley CD, et al. Cancer-related fatigue: the scale of the problem. Oncologist 2007; 12(1): 4-10. Go to original source... Go to PubMed...
    27. Yeo TP, Cannaday S. Cancer-related fatigue: impact on patient quality of life and management approaches. Nursing: research and reviews 2015; 2015(5): 65-76. Go to original source...
    28. Çetin EO, Isler C, Uzan M, et al. Epilepsy-related brain tumors. Seizure 2017; 44(Jan): 93-97. Go to original source...
    29. Armstrong TS, Grant R, Gilbert MR, et al. Epilepsy in glioma patients: mechanisms, management, and impact of anticonvulsant therapy. J Neuro Oncol 2016; 18(6): 779-789. Go to original source...
    30. Maschio M. Brain tumor-related epilepsy. Curr Neuropharmacol 2012; 10(2): 124-133. Go to original source...
    31. Kerkhof M, Vecht CJ. Seizure characteristics and prognostic factors of gliomas. Epilepsia 2013; 54(S9): 12-17. Go to original source...
    32. Lovely MP, Stewart-Amidei C, Page M, et al. A new reality: long-term survivorship with a malignant brain tumor. Oncol Nurs Forum 2013; 40(3): 267-274. Go to original source...
    33. Maurice C, Mason WP. Seizure management in patients with gliomas. Expert Rev Neurother 2014; 14(4): 367-377. Go to original source... Go to PubMed...
    34. Vecht CJ, Kerkhof M, Duran-Pena A. Seizure prognosis in brain tumors: new insights and evidence-based management. Oncologist 2014; 19(7): 751-759. Go to original source... Go to PubMed...
    35. Berendsen S, Varkila M, Kroonen J, et al. Prognostic relevance of epilepsy at presentation in glioblastoma patients. Neuro Oncol 2016; 18(5): 700-706. Go to original source...
    36. Toledo M, Sarria-Estrada S, Quintanaa M, et al. Epileptic features and survival in glioblastomas presenting with seizures. J Epilepsy Res 2017; 130(Feb): 1-6. Go to original source...
    37. Kehayov I, Kitov IBD, Zhelyazkov CB, et al. Neurocognitive impairments in brain tumor patients. Folia Med 2012; 54(1): 14-21. Go to original source...
    38. Back, M, Back E, Kastelan M, et al. Cognitive deficits in primary brain tumours: a framework for management and rehabilitation. J Cancer Ther 2014; 5(1), 74-81. Go to original source...
    39. Miotto C, Junior EAS, Silva CC, et al. Cognitive impairments in patients with low grade gliomas and high grade gliomas. Arq neuropsiquiatr 2010; 69(4): 596-601. Go to original source...
    40. Goebel S, Kaup L, Wiesner CD, et al. Affective state and cognitive functioning in patients with intracranial tumors: validity of the neuropsychological baseline assessment. Psycho-Oncol 2013; 22(6): 1319-1327. Go to original source... Go to PubMed...
    41. Cheng JX, Liu BL, Zhang X, et al. Health-related quality of life in glioma patients in China. BMC Cancer 2010; 10(305): 1-8. Go to original source...
    42. Bohan EM. Cognitive changes associated with central nervous system malignancies and treatment. Semin Oncol Nurs 2013; 29(4): 238-247. Go to original source... Go to PubMed...
    43. Mu YG, Huang LJ, Li SY, et al. Working memory and the identification of facial expression in patients with left frontal glioma. Neuro Oncol 2012; 14(Suppl. 4): iv81-iv89. Go to original source...
    44. Hendrix P, Hans E, Griessenauer CJ, et al. Neurocognitive status in patients with newly-diagnosed brain tumors in good neurological condition: the impact of tumor type, volume and location. Clin Neurol Neurosurg 2017; 156(Mar): 55-62. Go to original source...
    45. Southwell D, Riva M, Jordan K, et al. Language outcomes after resection of dominant inferior parietal lobule gliomas. J Neurosurg 2017; 2017(Jan): 1-9. 3 Go to original source...
    46. Adams H, Chaichana KL, Avendano J, et al. Adult cerebellar glioblastoma: understanding survival and prognostic factors using a population-based database from 1973 to 2009. World Neurosurg 2013; 80(6): 237-243. Go to original source...
    47. Hur H, Jung S, Jung TY, et al. Cerebellar glioblastoma multiforme in an adult. J Korean Neurosurg Soc 2008; 43(4): 194-197. Go to original source... Go to PubMed...

    Return to the content


    Oncology

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.